Lakewood-Amedex Biotherapeutics Inc. Common Stock
LABT
Rank in Stocks
#33184
This biopharmaceutical company is dedicated to developing innovative... This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
Share Price
$0.418
Last synced: 2026-11-09
Market Cap
$731.78K
Change (1 day)
8.21%
Change (1 year)
-
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)
Category
Healthcare
EPS for Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT)
EPS as of June 2026 TTM: $-10.02
According to Lakewood-Amedex Biotherapeutics Inc. Common Stock's latest financial reports, its current EPS (TTM) is $-10.02. At the end of 2025 the company had an EPS of $-2.76, an increase over its 2024 EPS of $-6.94.
EPS history for Lakewood-Amedex Biotherapeutics Inc. Common Stock from 2023 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-10.02 | 263.04% |
| 2025 | $-2.76 | -60.23% |
| 2024 | $-6.94 | -41.39% |
| 2023 | $-11.84 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -256.29% |
US
|
|
| $-7.07 | -29.44% |
US
|
|
| $-5.29 | -47.21% |
AU
|
|
| $12.88 | -228.54% |
BE
|
|
| $21.56 | -315.17% |
NL
|
Questions about Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS)
What is Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS)?
Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS) over the last twelve months is $-10.02, as of Jun 2026.
What was Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS) in 2025?
In 2025, Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS) was $-2.76, compared with $-6.94 in 2024.
How has Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS) changed since 2023?
From 2023 to 2025, Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS) was highest in 2025 ($-2.76) and lowest in 2023 ($-11.84).
How does Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS) compare with similar companies?
Lakewood-Amedex Biotherapeutics Inc. Common Stock's earnings per share (EPS) ($-10.02) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.